gefitinib has been researched along with sch772984 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (sch772984) | Trials (sch772984) | Recent Studies (post-2010) (sch772984) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 52 | 0 | 51 |
| Protein | Taxonomy | gefitinib (IC50) | sch772984 (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 3 | Homo sapiens (human) | 0.0084 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 0.0052 | |
| Dual specificity mitogen-activated protein kinase kinase 2 | Homo sapiens (human) | 0.009 | |
| Dual specificity mitogen-activated protein kinase kinase 1 | Homo sapiens (human) | 0.009 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baltes, F; Bendas, G; Caspers, J; Henze, S; Schlesinger, M | 1 |
1 other study(ies) available for gefitinib and sch772984
| Article | Year |
|---|---|
Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β
Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Collagen Type I; Discoidin Domain Receptor 1; Doxorubicin; Drug Resistance, Neoplasm; ErbB Receptors; Focal Adhesion Kinase 1; Gefitinib; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Indazoles; Integrin beta1; Integrin beta4; MAP Kinase Signaling System; MCF-7 Cells; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitoxantrone; Neoplasm Proteins; Piperazines; Tumor Microenvironment | 2020 |